Wegovy HD 7.2 mg Cost 2026: Is the High-Dose Worth It?
Key Takeaways
- Wegovy HD (7.2 mg) is the highest-dose semaglutide injection, costing $399/month through NovoCare
- That's $50/month more than the standard maintenance doses (0.25–2.4 mg at $349/month)
- Medicare Bridge covers Wegovy HD at the same $50/month flat copay
- Wegovy HD is injection-only — there is no oral equivalent at this dose level
- The higher dose may benefit patients who plateau on 2.4 mg or need additional weight loss
Wegovy HD is the 7.2 mg dose of semaglutide, tripling the standard maintenance dose of 2.4 mg. It's designed for patients who need more aggressive weight loss or who have plateaued on the standard maximum dose. As the highest-dose semaglutide product on the market, it carries a price premium — but a smaller one than you might expect.
Wegovy HD Pricing vs. Standard Doses
| Pricing Pathway | Standard Doses (0.25–2.4 mg) | Wegovy HD (7.2 mg) | Difference |
|---|---|---|---|
| NovoCare self-pay | $349/mo | $399/mo | +$50/mo |
| List price (retail) | $1,349/mo | $1,349/mo | Same list price |
| Insurance + savings card | $25/mo | $25/mo | Same |
| Medicare Bridge | $50/mo | $50/mo | Same |
| Subscription (3-month) | $329/mo | TBD | HD sub pricing TBD |
At $50/month more than standard NovoCare self-pay pricing, the Wegovy HD premium is relatively small — roughly 14% more per month. Through insurance or Medicare Bridge, there's no premium at all; the $25 and $50 copays cover all dose strengths equally.
Who Is Wegovy HD For?
The 7.2 mg dose isn't where everyone starts — or where everyone needs to be. It's designed for specific clinical situations:
- Plateau patients: People who achieved initial weight loss on 2.4 mg but have stopped losing
- Higher starting weight: Patients with higher BMIs may need more aggressive dosing to achieve meaningful weight loss
- Clinical judgment: Your prescriber determines whether the higher dose is appropriate based on your response, side effects, and goals
You can't start on 7.2 mg — the standard titration protocol takes you through the lower doses first (0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg), with increases approximately every 4 weeks. Only after reaching 2.4 mg would your provider consider stepping up to 7.2 mg.
HD vs. Oral Pills: A Format Choice
There is no oral Wegovy equivalent to the 7.2 mg injection dose. The Wegovy pill maxes out at 25 mg oral semaglutide, which delivers roughly comparable efficacy to the 2.4 mg injection — not the 7.2 mg.
So if your clinical plan requires the highest available dose of semaglutide, injection is your only option. The question becomes whether the incremental benefit of 7.2 mg vs. 2.4 mg justifies the format (injection) and the $50/month premium over the oral pill at maintenance.
Compounded Alternatives
Compounded semaglutide providers can theoretically prepare doses at any strength, including equivalents to the 7.2 mg level. However, higher doses use more active ingredient, so pricing may be higher than entry-level compounded pricing. Always confirm your maintenance dose cost with the provider.
Injectable semaglutide
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Injectable
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Wegovy HD at $399/month is only $50/month more than standard Wegovy through NovoCare — and the same price through insurance and Medicare ($25 or $50/month). The real question isn't whether HD is worth the premium (it's modest), but whether the higher dose is clinically right for you. That's a conversation with your prescriber based on your response to the standard 2.4 mg dose.
Prices verified as of July 15, 2026. Wegovy HD (7.2 mg) is a prescription medication requiring specific clinical criteria. Consult your healthcare provider about dose appropriateness.